Get the Stockscreener App
2.88
2.37%
-0.07
After Hours:
2.81
-0.07
-2.43%
Psyence Biomedical Ltd stock is traded at $2.88, with a volume of 24,199.
It is down -2.37% in the last 24 hours and up +17.07% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$2.95
Open:
$2.7406
24h Volume:
24,199
Relative Volume:
0.10
Market Cap:
$6.60M
Revenue:
-
Net Income/Loss:
$1.52M
P/E Ratio:
-0.4556
EPS:
-6.3213
Net Cash Flow:
$-1.14M
1W Performance:
+15.66%
1M Performance:
+17.07%
6M Performance:
-86.98%
1Y Performance:
-88.30%
1-Day Range:
$2.7406
$2.91
1-Week Range:
$2.4101
$2.95
52-Week Range:
$0.6254
$74.94
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
2.88 | 6.77M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Psyence Biomedical Ltd Stock (PBM) Latest News
Psyence Biomedical Expands Australian Psilocybin Trial Network to Five Sites - TipRanks
Psyence BioMed (NASDAQ: PBM) expands to five Australian sites for NPX-5 trial - Stock Titan
Aug Gainers: Will Psyence Biomedical Ltd benefit from seasonality2026 Sector Moves & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Trade Recap: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Product Launch & Safe Capital Preservation Plans - baoquankhu1.vn
Bank Watch: Can STSS weather a recessionMarket Sentiment Review & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Fed Meeting: Will Psyence Biomedical Ltd outperform its industry peers2026 Setups & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities - Sahm
Psyence Biomedical Ltd Expands Australian Clinical Site Network And Advances NPX-5 Supported Clinical Activities - marketscreener.com
Psyence Biomedical expands Australian clinical sites to five - Investing.com
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5-Supported Clinical Activities - The Manila Times
Psyence Biomedical expands Australian clinical sites to five By Investing.com - in.investing.com
Australia cancer trial adds 2 sites as Psyence expands psilocybin study - Stock Titan
Aug Momentum: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysisRecession Risk & Safe Entry Point Alerts - baoquankhu1.vn
Retail Trends: Is AlphaVest Acquisition Corp Debt Equity Composite Units a potential multi baggerLayoff News & Technical Buy Zone Confirmation - baoquankhu1.vn
Stop Loss: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysis2026 Breakouts & Risk Managed Investment Strategies - baoquankhu1.vn
PBM Stock Price, Quote & Chart | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Will Freshworks Inc. stock benefit from sector rotationWeekly Profit Recap & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Psyence Biomedical shares rise following equity investment agreement - MSN
Will Psyence Biomedical Ltd Equity Warrant be affected by tariffs2026 Sector Moves & Safe Capital Growth Tips - baoquankhu1.vn
Price Action: Can Aureus Greenway Holdings Inc grow without dilutionExit Point & Fast Moving Stock Watchlists - baoquankhu1.vn
PBM Technical Analysis & Stock Price Forecast - Intellectia AI
Hedge Fund Bets: Will Psyence Biomedical Ltd Equity Warrant benefit from government policy2026 Momentum Check & Community Verified Watchlist Alerts - baoquankhu1.vn
Buyout Rumor: Is Psyence Biomedical Ltd a top pick in the sectorTrade Volume Report & Smart Money Movement Alerts - baoquankhu1.vn
Investment Review: Is Psyence Biomedical Ltd Equity Warrant a cyclical or defensive stockWeekly Trade Analysis & Risk Managed Trade Strategies - baoquankhu1.vn
Trend Review: Is Psyence Biomedical Ltd Equity Warrant stock risky to hold now2026 Snapshot & Verified Momentum Stock Watchlist - baoquankhu1.vn
PBM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Weekly Recap: What drives Garrett Motion Incs stock priceShare Buyback & Weekly Top Gainers Alerts - baoquankhu1.vn
Is Psyence Biomedical Ltd stock a good pick for beginners2026 Trade Ideas & Safe Entry Point Identification - baoquankhu1.vn
PBM Should I Buy - Intellectia AI
Psyence Biomedical Ltd. (PBM) Achieves Breakthrough in High-Purity Ibogaine Production - MSN
Portfolio Recap: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2026 PostEarnings & Stepwise Trade Execution Plans - baoquankhu1.vn
IPO Launch: Is Psyence Biomedical Ltd stock influenced by commodity pricesTrade Volume Report & Weekly High Return Stock Forecasts - baoquankhu1.vn
PBM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Psyence Biomedical announces milestone in natural ibogaine HCl production - MSN
Market Recap: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Earnings Growth Report & Breakout Confirmation Alerts - baoquankhu1.vn
Energy Moves: Is Psyence Biomedical Ltd in a bullish channelTrade Risk Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
PBM.O PE Ratio & Valuation, Is PBM.O Overvalued - Intellectia AI
PBM News & Events - Intellectia AI
Big Money Moves: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysis2026 Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Institution Moves: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Insider Buying & Daily Stock Momentum Reports - baoquankhu1.vn
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone - The Manila Times
Psyence Biomedical Ltd. Strengthens Pharmaceutical-Grade Manufacturing Capabilities Through Strategic Investment in PsyLabs - Quiver Quantitative
Aug Rallies: Is 1stdibsCom Inc stock a smart retirement pick2026 PreEarnings & AI Driven Stock Reports - baoquankhu1.vn
Aug Highlights: Will Psyence Biomedical Ltd. Equity Warrant be affected by tariffs2026 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn
Death Cross: Whats the beta of Psyence Biomedical Ltd stockPortfolio Growth Summary & High Win Rate Trade Tips - baoquankhu1.vn
Can Psyence Biomedical Ltd. stock withstand economic slowdownJuly 2025 Intraday Action & Accurate Entry and Exit Point Alerts - Naître et grandir
Market Outlook: Will Psyence Biomedical Ltd Equity Warrant benefit from government policyTrade Exit Summary & Long-Term Capital Growth Ideas - baoquankhu1.vn
Aug PostEarnings: Will Psyence Biomedical Ltd outperform its industry peers2025 Trade Ideas & Precise Trade Entry Recommendations - baoquankhu1.vn
Gainers Report: Is Psyence Biomedical Ltd a top pick in the sector2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science - Stocktwits
How Psyence Biomedical Ltd. stock performs in interest rate cyclesWall Street Watch & High Yield Equity Trading Tips - mfd.ru
Psyence Biomedical Ltd Stock (PBM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):